Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study
Peak lung function and rate of decline predict future airflow obstruction and nonrespiratory comorbid conditions. Associations between lung function trajectories and emphysema have not been explored. Using data from the population-based CARDIA Study, we sought to describe the prevalence of visually...
Gespeichert in:
Veröffentlicht in: | The American journal of medicine 2020-02, Vol.133 (2), p.222-230.e11 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 230.e11 |
---|---|
container_issue | 2 |
container_start_page | 222 |
container_title | The American journal of medicine |
container_volume | 133 |
creator | Washko, George R. Colangelo, Laura A. Estépar, Raul San José Ash, Samuel Y. Bhatt, Surya P. Okajima, Yuka Liu, Kiang Jacobs, David R. Iribarren, Carlos Thyagarajan, Bharat Lewis, Cora E. Kumar, Rajesh Han, MeiLan K. Dransfield, Mark T. Carnethon, Mercedes R. Kalhan, Ravi |
description | Peak lung function and rate of decline predict future airflow obstruction and nonrespiratory comorbid conditions. Associations between lung function trajectories and emphysema have not been explored.
Using data from the population-based CARDIA Study, we sought to describe the prevalence of visually ascertained emphysema at multiple time points and contextualize its development based upon participant’s adult life course measures of lung function. There were 3171 men and women enrolled at a mean age of 25 years, who underwent serial spirometric examinations through a mean age of 55 years. Trajectories for the change in percent-predicted forced expiratory volume in one second (FEV1) were determined by fitting a mixture model via maximum likelihood. Emphysema was visually identified on computed tomographic scans and its prevalence reported at mean ages of 40, 45, and 50 years.
We identified 5 trajectories describing peak and change in FEV1: “Preserved Ideal,” “Preserved Good,” “Preserved Impaired,” “Worsening,” and “Persistently Poor.” Ever smokers comprised part of all 5 trajectories. The prevalence of emphysema was 1.7% (n = 46; mean age of 40 years), 2.5% (n = 67; mean age of 45 years), and 7.1% (n = 189; mean age of 50 years). Of those with emphysema at a mean age of 50 years, 18.0% were never smokers. Worsening and poor lung health trajectories were associated with increased odds of future emphysema independent of chronic tobacco smoke exposure (odds ratio 5.06; confidence interval, 1.84-13.96; odds ratio 4.85; confidence interval, 1.43-16.44).
Lower peak and accelerated decline in FEV1 are risk factors for future emphysema independent of smoking status. |
doi_str_mv | 10.1016/j.amjmed.2019.06.049 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_31369720</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000293431930600X</els_id><sourcerecordid>2268315191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-240fea59ae772ebc612dc34ba187e9e766d55104104e32db3a3533fd85e502b73</originalsourceid><addsrcrecordid>eNqNkl2L1DAUQIMo7uzqPxDpo7C05qNJJz4IQ3dXFwYEHZ9D2tzOpLTNmLQj8-_N0NlRX0QIJOGee3OTE4TeEJwRTMT7NtN924PJKCYywyLDuXyGFoRznhZE0OdogTGmqWQ5u0LXIbRxiyUXL9EVI0zIguIF2q7M1I3J2jaQlm7yAZKN1y3Uo_MWQuKaZD0N2-RhGurRuiHRg0nGHSR3cIDO7XsYxhN03-93xwC9_pBsYrRcfb17XM2p38bJHF-hF43uArw-zzfo-8P9pvycrr98eixX67TmVI4pzXEDmksNRUGhqgWhpmZ5pcmyAAmFEIZzgvM4gFFTMc04Y41ZcuCYVgW7QR_nuvupio9Tx_a87tTe2177o3Laqr8jg92prTsoIZeY8jwWeHcu4N2PCcKoehtq6Do9gJuColQsGeFEkojmM1p7F4KH5nIMwerkSLVqdqROjhQWKjqKaW__bPGS9CQlArcz8BMq14TawlDDBYsSOS6YpDSuchbp5f_TpR31SWNUPYy_HwuikYMFr87pxvr4A5Rx9t9X-QX26MV0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2268315191</pqid></control><display><type>article</type><title>Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study</title><source>MEDLINE</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>Access via ScienceDirect (Elsevier)</source><creator>Washko, George R. ; Colangelo, Laura A. ; Estépar, Raul San José ; Ash, Samuel Y. ; Bhatt, Surya P. ; Okajima, Yuka ; Liu, Kiang ; Jacobs, David R. ; Iribarren, Carlos ; Thyagarajan, Bharat ; Lewis, Cora E. ; Kumar, Rajesh ; Han, MeiLan K. ; Dransfield, Mark T. ; Carnethon, Mercedes R. ; Kalhan, Ravi</creator><creatorcontrib>Washko, George R. ; Colangelo, Laura A. ; Estépar, Raul San José ; Ash, Samuel Y. ; Bhatt, Surya P. ; Okajima, Yuka ; Liu, Kiang ; Jacobs, David R. ; Iribarren, Carlos ; Thyagarajan, Bharat ; Lewis, Cora E. ; Kumar, Rajesh ; Han, MeiLan K. ; Dransfield, Mark T. ; Carnethon, Mercedes R. ; Kalhan, Ravi</creatorcontrib><description>Peak lung function and rate of decline predict future airflow obstruction and nonrespiratory comorbid conditions. Associations between lung function trajectories and emphysema have not been explored.
Using data from the population-based CARDIA Study, we sought to describe the prevalence of visually ascertained emphysema at multiple time points and contextualize its development based upon participant’s adult life course measures of lung function. There were 3171 men and women enrolled at a mean age of 25 years, who underwent serial spirometric examinations through a mean age of 55 years. Trajectories for the change in percent-predicted forced expiratory volume in one second (FEV1) were determined by fitting a mixture model via maximum likelihood. Emphysema was visually identified on computed tomographic scans and its prevalence reported at mean ages of 40, 45, and 50 years.
We identified 5 trajectories describing peak and change in FEV1: “Preserved Ideal,” “Preserved Good,” “Preserved Impaired,” “Worsening,” and “Persistently Poor.” Ever smokers comprised part of all 5 trajectories. The prevalence of emphysema was 1.7% (n = 46; mean age of 40 years), 2.5% (n = 67; mean age of 45 years), and 7.1% (n = 189; mean age of 50 years). Of those with emphysema at a mean age of 50 years, 18.0% were never smokers. Worsening and poor lung health trajectories were associated with increased odds of future emphysema independent of chronic tobacco smoke exposure (odds ratio 5.06; confidence interval, 1.84-13.96; odds ratio 4.85; confidence interval, 1.43-16.44).
Lower peak and accelerated decline in FEV1 are risk factors for future emphysema independent of smoking status.</description><identifier>ISSN: 0002-9343</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/j.amjmed.2019.06.049</identifier><identifier>PMID: 31369720</identifier><language>eng</language><publisher>NEW YORK: Elsevier Inc</publisher><subject>Adult ; Cohort Studies ; Emphysema risk ; Female ; Forced Expiratory Volume ; General & Internal Medicine ; Humans ; Life Sciences & Biomedicine ; Longitudinal Studies ; Lung function trajectory ; Male ; Medicine, General & Internal ; Middle Aged ; Odds Ratio ; Pulmonary Emphysema ; Respiratory Function Tests ; Risk Factors ; Science & Technology ; Spirometry</subject><ispartof>The American journal of medicine, 2020-02, Vol.133 (2), p.222-230.e11</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>28</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000507392200043</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c529t-240fea59ae772ebc612dc34ba187e9e766d55104104e32db3a3533fd85e502b73</citedby><cites>FETCH-LOGICAL-c529t-240fea59ae772ebc612dc34ba187e9e766d55104104e32db3a3533fd85e502b73</cites><orcidid>0000-0001-9489-9747 ; 0000-0002-1962-7108 ; 0000-0002-7232-0543</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.amjmed.2019.06.049$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,315,782,786,887,3552,27931,27932,28255,46002</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31369720$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Washko, George R.</creatorcontrib><creatorcontrib>Colangelo, Laura A.</creatorcontrib><creatorcontrib>Estépar, Raul San José</creatorcontrib><creatorcontrib>Ash, Samuel Y.</creatorcontrib><creatorcontrib>Bhatt, Surya P.</creatorcontrib><creatorcontrib>Okajima, Yuka</creatorcontrib><creatorcontrib>Liu, Kiang</creatorcontrib><creatorcontrib>Jacobs, David R.</creatorcontrib><creatorcontrib>Iribarren, Carlos</creatorcontrib><creatorcontrib>Thyagarajan, Bharat</creatorcontrib><creatorcontrib>Lewis, Cora E.</creatorcontrib><creatorcontrib>Kumar, Rajesh</creatorcontrib><creatorcontrib>Han, MeiLan K.</creatorcontrib><creatorcontrib>Dransfield, Mark T.</creatorcontrib><creatorcontrib>Carnethon, Mercedes R.</creatorcontrib><creatorcontrib>Kalhan, Ravi</creatorcontrib><title>Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study</title><title>The American journal of medicine</title><addtitle>AM J MED</addtitle><addtitle>Am J Med</addtitle><description>Peak lung function and rate of decline predict future airflow obstruction and nonrespiratory comorbid conditions. Associations between lung function trajectories and emphysema have not been explored.
Using data from the population-based CARDIA Study, we sought to describe the prevalence of visually ascertained emphysema at multiple time points and contextualize its development based upon participant’s adult life course measures of lung function. There were 3171 men and women enrolled at a mean age of 25 years, who underwent serial spirometric examinations through a mean age of 55 years. Trajectories for the change in percent-predicted forced expiratory volume in one second (FEV1) were determined by fitting a mixture model via maximum likelihood. Emphysema was visually identified on computed tomographic scans and its prevalence reported at mean ages of 40, 45, and 50 years.
We identified 5 trajectories describing peak and change in FEV1: “Preserved Ideal,” “Preserved Good,” “Preserved Impaired,” “Worsening,” and “Persistently Poor.” Ever smokers comprised part of all 5 trajectories. The prevalence of emphysema was 1.7% (n = 46; mean age of 40 years), 2.5% (n = 67; mean age of 45 years), and 7.1% (n = 189; mean age of 50 years). Of those with emphysema at a mean age of 50 years, 18.0% were never smokers. Worsening and poor lung health trajectories were associated with increased odds of future emphysema independent of chronic tobacco smoke exposure (odds ratio 5.06; confidence interval, 1.84-13.96; odds ratio 4.85; confidence interval, 1.43-16.44).
Lower peak and accelerated decline in FEV1 are risk factors for future emphysema independent of smoking status.</description><subject>Adult</subject><subject>Cohort Studies</subject><subject>Emphysema risk</subject><subject>Female</subject><subject>Forced Expiratory Volume</subject><subject>General & Internal Medicine</subject><subject>Humans</subject><subject>Life Sciences & Biomedicine</subject><subject>Longitudinal Studies</subject><subject>Lung function trajectory</subject><subject>Male</subject><subject>Medicine, General & Internal</subject><subject>Middle Aged</subject><subject>Odds Ratio</subject><subject>Pulmonary Emphysema</subject><subject>Respiratory Function Tests</subject><subject>Risk Factors</subject><subject>Science & Technology</subject><subject>Spirometry</subject><issn>0002-9343</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqNkl2L1DAUQIMo7uzqPxDpo7C05qNJJz4IQ3dXFwYEHZ9D2tzOpLTNmLQj8-_N0NlRX0QIJOGee3OTE4TeEJwRTMT7NtN924PJKCYywyLDuXyGFoRznhZE0OdogTGmqWQ5u0LXIbRxiyUXL9EVI0zIguIF2q7M1I3J2jaQlm7yAZKN1y3Uo_MWQuKaZD0N2-RhGurRuiHRg0nGHSR3cIDO7XsYxhN03-93xwC9_pBsYrRcfb17XM2p38bJHF-hF43uArw-zzfo-8P9pvycrr98eixX67TmVI4pzXEDmksNRUGhqgWhpmZ5pcmyAAmFEIZzgvM4gFFTMc04Y41ZcuCYVgW7QR_nuvupio9Tx_a87tTe2177o3Laqr8jg92prTsoIZeY8jwWeHcu4N2PCcKoehtq6Do9gJuColQsGeFEkojmM1p7F4KH5nIMwerkSLVqdqROjhQWKjqKaW__bPGS9CQlArcz8BMq14TawlDDBYsSOS6YpDSuchbp5f_TpR31SWNUPYy_HwuikYMFr87pxvr4A5Rx9t9X-QX26MV0</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Washko, George R.</creator><creator>Colangelo, Laura A.</creator><creator>Estépar, Raul San José</creator><creator>Ash, Samuel Y.</creator><creator>Bhatt, Surya P.</creator><creator>Okajima, Yuka</creator><creator>Liu, Kiang</creator><creator>Jacobs, David R.</creator><creator>Iribarren, Carlos</creator><creator>Thyagarajan, Bharat</creator><creator>Lewis, Cora E.</creator><creator>Kumar, Rajesh</creator><creator>Han, MeiLan K.</creator><creator>Dransfield, Mark T.</creator><creator>Carnethon, Mercedes R.</creator><creator>Kalhan, Ravi</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9489-9747</orcidid><orcidid>https://orcid.org/0000-0002-1962-7108</orcidid><orcidid>https://orcid.org/0000-0002-7232-0543</orcidid></search><sort><creationdate>20200201</creationdate><title>Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study</title><author>Washko, George R. ; Colangelo, Laura A. ; Estépar, Raul San José ; Ash, Samuel Y. ; Bhatt, Surya P. ; Okajima, Yuka ; Liu, Kiang ; Jacobs, David R. ; Iribarren, Carlos ; Thyagarajan, Bharat ; Lewis, Cora E. ; Kumar, Rajesh ; Han, MeiLan K. ; Dransfield, Mark T. ; Carnethon, Mercedes R. ; Kalhan, Ravi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-240fea59ae772ebc612dc34ba187e9e766d55104104e32db3a3533fd85e502b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Cohort Studies</topic><topic>Emphysema risk</topic><topic>Female</topic><topic>Forced Expiratory Volume</topic><topic>General & Internal Medicine</topic><topic>Humans</topic><topic>Life Sciences & Biomedicine</topic><topic>Longitudinal Studies</topic><topic>Lung function trajectory</topic><topic>Male</topic><topic>Medicine, General & Internal</topic><topic>Middle Aged</topic><topic>Odds Ratio</topic><topic>Pulmonary Emphysema</topic><topic>Respiratory Function Tests</topic><topic>Risk Factors</topic><topic>Science & Technology</topic><topic>Spirometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Washko, George R.</creatorcontrib><creatorcontrib>Colangelo, Laura A.</creatorcontrib><creatorcontrib>Estépar, Raul San José</creatorcontrib><creatorcontrib>Ash, Samuel Y.</creatorcontrib><creatorcontrib>Bhatt, Surya P.</creatorcontrib><creatorcontrib>Okajima, Yuka</creatorcontrib><creatorcontrib>Liu, Kiang</creatorcontrib><creatorcontrib>Jacobs, David R.</creatorcontrib><creatorcontrib>Iribarren, Carlos</creatorcontrib><creatorcontrib>Thyagarajan, Bharat</creatorcontrib><creatorcontrib>Lewis, Cora E.</creatorcontrib><creatorcontrib>Kumar, Rajesh</creatorcontrib><creatorcontrib>Han, MeiLan K.</creatorcontrib><creatorcontrib>Dransfield, Mark T.</creatorcontrib><creatorcontrib>Carnethon, Mercedes R.</creatorcontrib><creatorcontrib>Kalhan, Ravi</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Washko, George R.</au><au>Colangelo, Laura A.</au><au>Estépar, Raul San José</au><au>Ash, Samuel Y.</au><au>Bhatt, Surya P.</au><au>Okajima, Yuka</au><au>Liu, Kiang</au><au>Jacobs, David R.</au><au>Iribarren, Carlos</au><au>Thyagarajan, Bharat</au><au>Lewis, Cora E.</au><au>Kumar, Rajesh</au><au>Han, MeiLan K.</au><au>Dransfield, Mark T.</au><au>Carnethon, Mercedes R.</au><au>Kalhan, Ravi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study</atitle><jtitle>The American journal of medicine</jtitle><stitle>AM J MED</stitle><addtitle>Am J Med</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>133</volume><issue>2</issue><spage>222</spage><epage>230.e11</epage><pages>222-230.e11</pages><issn>0002-9343</issn><eissn>1555-7162</eissn><abstract>Peak lung function and rate of decline predict future airflow obstruction and nonrespiratory comorbid conditions. Associations between lung function trajectories and emphysema have not been explored.
Using data from the population-based CARDIA Study, we sought to describe the prevalence of visually ascertained emphysema at multiple time points and contextualize its development based upon participant’s adult life course measures of lung function. There were 3171 men and women enrolled at a mean age of 25 years, who underwent serial spirometric examinations through a mean age of 55 years. Trajectories for the change in percent-predicted forced expiratory volume in one second (FEV1) were determined by fitting a mixture model via maximum likelihood. Emphysema was visually identified on computed tomographic scans and its prevalence reported at mean ages of 40, 45, and 50 years.
We identified 5 trajectories describing peak and change in FEV1: “Preserved Ideal,” “Preserved Good,” “Preserved Impaired,” “Worsening,” and “Persistently Poor.” Ever smokers comprised part of all 5 trajectories. The prevalence of emphysema was 1.7% (n = 46; mean age of 40 years), 2.5% (n = 67; mean age of 45 years), and 7.1% (n = 189; mean age of 50 years). Of those with emphysema at a mean age of 50 years, 18.0% were never smokers. Worsening and poor lung health trajectories were associated with increased odds of future emphysema independent of chronic tobacco smoke exposure (odds ratio 5.06; confidence interval, 1.84-13.96; odds ratio 4.85; confidence interval, 1.43-16.44).
Lower peak and accelerated decline in FEV1 are risk factors for future emphysema independent of smoking status.</abstract><cop>NEW YORK</cop><pub>Elsevier Inc</pub><pmid>31369720</pmid><doi>10.1016/j.amjmed.2019.06.049</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0001-9489-9747</orcidid><orcidid>https://orcid.org/0000-0002-1962-7108</orcidid><orcidid>https://orcid.org/0000-0002-7232-0543</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9343 |
ispartof | The American journal of medicine, 2020-02, Vol.133 (2), p.222-230.e11 |
issn | 0002-9343 1555-7162 |
language | eng |
recordid | cdi_pubmed_primary_31369720 |
source | MEDLINE; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; Access via ScienceDirect (Elsevier) |
subjects | Adult Cohort Studies Emphysema risk Female Forced Expiratory Volume General & Internal Medicine Humans Life Sciences & Biomedicine Longitudinal Studies Lung function trajectory Male Medicine, General & Internal Middle Aged Odds Ratio Pulmonary Emphysema Respiratory Function Tests Risk Factors Science & Technology Spirometry |
title | Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T23%3A55%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adult%20Life-Course%20Trajectories%20of%20Lung%20Function%20and%20the%20Development%20of%20Emphysema:%20The%20CARDIA%20Lung%20Study&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Washko,%20George%20R.&rft.date=2020-02-01&rft.volume=133&rft.issue=2&rft.spage=222&rft.epage=230.e11&rft.pages=222-230.e11&rft.issn=0002-9343&rft.eissn=1555-7162&rft_id=info:doi/10.1016/j.amjmed.2019.06.049&rft_dat=%3Cproquest_pubme%3E2268315191%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2268315191&rft_id=info:pmid/31369720&rft_els_id=S000293431930600X&rfr_iscdi=true |